FOGLIETTA, MYRIAM
FOGLIETTA, MYRIAM
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
2015-01-01 Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M.
Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method
2009-01-01 Mariani S; Hwang SY; Foglietta M; Bonello L; Vitale C; Coscia M; Fiore F; Bruno B; Massaia M.
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
2020-01-01 Scarfo L.; Chatzikonstantinou T.; Rigolin G.M.; Quaresmini G.; Motta M.; Vitale C.; Garcia-Marco J.A.; Hernandez-Rivas J.A.; Miras F.; Baile M.; Marquet J.; Niemann C.U.; Reda G.; Munir T.; Gimeno E.; Marchetti M.; Quaglia F.M.; Varettoni M.; Delgado J.; Iyengar S.; Janssens A.; Marasca R.; Ferrari A.; Cuellar-Garcia C.; Itchaki G.; Spacek M.; De Paoli L.; Laurenti L.; Levin M.-D.; Lista E.; Mauro F.R.; Simkovic M.; Van Der Spek E.; Vandenberghe E.; Trentin L.; Wasik-Szczepanek E.; Ruchlemer R.; Bron D.; De Paolis M.R.; Del Poeta G.; Farina L.; Foglietta M.; Gentile M.; Herishanu Y.; Herold T.; Jaksic O.; Kater A.P.; Kersting S.; Malerba L.; Orsucci L.; Popov V.M.; Sportoletti P.; Yassin M.; Pocali B.; Barna G.; Chiarenza A.; dos Santos G.; Nikitin E.; Andres M.; Dimou M.; Doubek M.; Enrico A.; Hakobyan Y.; Kalashnikova O.; Ortiz Pareja M.; Papaioannou M.; Rossi D.; Shah N.; Shrestha A.; Stanca O.; Stavroyianni N.; Strugov V.; Tam C.; Zdrenghea M.; Coscia M.; Stamatopoulos K.; Rossi G.; Rambaldi A.; Montserrat E.; Foa R.; Cuneo A.; Ghia P.
Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases
2021-01-01 Castellino A.; Elba S.; Sorasio R.; Castellino C.; Bonferroni M.; Grasso M.; Grosso E.; Giacchello R.; Signorile A.F.; Celeghini I.; Mattei D.; Mordini N.; Foglietta M.; Masturzo B.; Priotto R.; Zonta A.; Rapezzi D.; Massaia M.
Distribution of γδ T cells in patients with hematological malignancies
2006-01-01 Mariani, S; Pantaleoni, F.; Peola, S.; Hwang, S.Y.; Castella, B.; Matta, G.; Foglietta, M.; Fiore, F.; Coscia, M.A.; Boccadoro, M.; Massaia, M.
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
2012-01-01 Coscia M; Vitale C; Peola S; Foglietta M; Rigoni M; Griggio V; Castella B; Angelini D; Chiaretti S; Riganti C; Guarini A; Drandi D; Ladetto M; Bosia A; Foà R; Battistini L; Boccadoro M; Fournié JJ; Massaia M.
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma
2005-01-01 Mariani S; Muraro M; Pantaleoni F; Fiore F; Nuschak B; Peola S; Foglietta M; Palumbo A; Coscia M; Castella B; Bruno B; Bertieri R; Boano L; Boccadoro M; Massaia M
Enhanced ability of dendritic cells to stimulate innate and adaptive immunity upon short-term incubation with zoledronic acid
2007-01-01 FIORE F; CASTELLA B; NUSCHAK B; BERTIERI R; MARIANI S; BRUNO B; PANTALEONI F; FOGLIETTA M; BOCCADORO M; MASSAIA M
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells
2005-01-01 F. FIORE; B. NUSCHAK; S. PEOLA; S. MARIANI; M. MURARO; M. FOGLIETTA; M. COSCIA; B. BRUNO; M. BOCCADORO; M. MASSAIA
Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma
2006-01-01 Foglietta M; Mariani S; Castella B; Coscia M; Boccadoro M; Massaia M
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia
2016-01-01 Griggio, Valentina; Mandili, Giorgia; Vitale, Candida; Capello, Michela; Macor, Paolo; Serra, Sara; Castella, Barbara; Peola, Silvia; Foglietta, Myriam; Drandi, Daniela; Omedé, Paola; Sblattero, Daniele; Cappello, Paola; Chiarle, Roberto; Deaglio, Silvia; Boccadoro, Mario; Novelli, Francesco; Massaia, Massimo; Coscia, Marta
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2014-01-01 Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Macor P; Novelli F; Boccadoro M; Massaia M; Coscia M.
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia
2014-01-01 Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Canepari ME; Novelli F; Boccadoro M; Massaia M; Coscia M
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA)
2012-01-01 Marta Coscia; Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Marta Robino; Marina Ruggeri; Daniela Drandi; Paola Omedè; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells
2011-01-01 Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M.
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross Talk between V{gamma}9V{delta}2 T Cells, {alpha}{beta} CD8+ T Cells, Regulatory T Cells, and Dendritic Cells
2011-01-01 Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M
Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: Diagnostic challenges and therapeutic options: Two case reports
2020-01-01 Elba S.; Castellino A.; Soriasio R.; Castellino C.; Bonferroni M.; Mattei D.; Strola G.; Drandi D.; Mordini N.; Foglietta M.; Rapezzi D.; Celeghini I.; Grasso M.; Giordano F.; Fraternali Orcioni G.; Massaia M.
Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients.
2000-01-01 BESOSTRI B ;BEGGIATO E ;BIANCHI A ;MARIANI S ;COSCIA M ;PEOLA S ;FOGLIETTA M ;BOCCADORO M ;PILERI A ;MORETTA L ;MASSAIA M
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy
2004-01-01 COSCIA M; MARIANI S; BATTAGLIO S; DI BELLO C; FIORE F; FOGLIETTA M; PILERI A; BOCCADORO M; MASSAIA M
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway.
2014-01-01 P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma | 2015 | Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M. | |
| Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method | 2009 | Mariani S; Hwang SY; Foglietta M; Bonello L; Vitale C; Coscia M; Fiore F; Bruno B; Massaia M. | |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus | 2020 | Scarfo L.; Chatzikonstantinou T.; Rigolin G.M.; Quaresmini G.; Motta M.; Vitale C.; Garcia-Marco J.A.; Hernandez-Rivas J.A.; Miras F.; Baile M.; Marquet J.; Niemann C.U.; Reda G.; Munir T.; Gimeno E.; Marchetti M.; Quaglia F.M.; Varettoni M.; Delgado J.; Iyengar S.; Janssens A.; Marasca R.; Ferrari A.; Cuellar-Garcia C.; Itchaki G.; Spacek M.; De Paoli L.; Laurenti L.; Levin M.-D.; Lista E.; Mauro F.R.; Simkovic M.; Van Der Spek E.; Vandenberghe E.; Trentin L.; Wasik-Szczepanek E.; Ruchlemer R.; Bron D.; De Paolis M.R.; Del Poeta G.; Farina L.; Foglietta M.; Gentile M.; Herishanu Y.; Herold T.; Jaksic O.; Kater A.P.; Kersting S.; Malerba L.; Orsucci L.; Popov V.M.; Sportoletti P.; Yassin M.; Pocali B.; Barna G.; Chiarenza A.; dos Santos G.; Nikitin E.; Andres M.; Dimou M.; Doubek M.; Enrico A.; Hakobyan Y.; Kalashnikova O.; Ortiz Pareja M.; Papaioannou M.; Rossi D.; Shah N.; Shrestha A.; Stanca O.; Stavroyianni N.; Strugov V.; Tam C.; Zdrenghea M.; Coscia M.; Stamatopoulos K.; Rossi G.; Rambaldi A.; Montserrat E.; Foa R.; Cuneo A.; Ghia P. | |
| Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases | 2021 | Castellino A.; Elba S.; Sorasio R.; Castellino C.; Bonferroni M.; Grasso M.; Grosso E.; Giacchello R.; Signorile A.F.; Celeghini I.; Mattei D.; Mordini N.; Foglietta M.; Masturzo B.; Priotto R.; Zonta A.; Rapezzi D.; Massaia M. | |
| Distribution of γδ T cells in patients with hematological malignancies | 2006 | Mariani, S; Pantaleoni, F.; Peola, S.; Hwang, S.Y.; Castella, B.; Matta, G.; Foglietta, M.; Fiore, F.; Coscia, M.A.; Boccadoro, M.; Massaia, M. | |
| Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. | 2012 | Coscia M; Vitale C; Peola S; Foglietta M; Rigoni M; Griggio V; Castella B; Angelini D; Chiaretti S; Riganti C; Guarini A; Drandi D; Ladetto M; Bosia A; Foà R; Battistini L; Boccadoro M; Fournié JJ; Massaia M. | |
| Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma | 2005 | Mariani S; Muraro M; Pantaleoni F; Fiore F; Nuschak B; Peola S; Foglietta M; Palumbo A; Coscia M; Castella B; Bruno B; Bertieri R; Boano L; Boccadoro M; Massaia M | |
| Enhanced ability of dendritic cells to stimulate innate and adaptive immunity upon short-term incubation with zoledronic acid | 2007 | FIORE F; CASTELLA B; NUSCHAK B; BERTIERI R; MARIANI S; BRUNO B; PANTALEONI F; FOGLIETTA M; BOCCADORO M; MASSAIA M | |
| Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells | 2005 | F. FIORE; B. NUSCHAK; S. PEOLA; S. MARIANI; M. MURARO; M. FOGLIETTA; M. COSCIA; B. BRUNO; M. BOCCADORO; M. MASSAIA | |
| Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma | 2006 | Foglietta M; Mariani S; Castella B; Coscia M; Boccadoro M; Massaia M | |
| Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia | 2016 | Griggio, Valentina; Mandili, Giorgia; Vitale, Candida; Capello, Michela; Macor, Paolo; Serra, Sara; Castella, Barbara; Peola, Silvia; Foglietta, Myriam; Drandi, Daniela; Omedé, Paola; Sblattero, Daniele; Cappello, Paola; Chiarle, Roberto; Deaglio, Silvia; Boccadoro, Mario; Novelli, Francesco; Massaia, Massimo; Coscia, Marta | |
| IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2014 | Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Macor P; Novelli F; Boccadoro M; Massaia M; Coscia M. | |
| Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia | 2014 | Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Canepari ME; Novelli F; Boccadoro M; Massaia M; Coscia M | |
| Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) | 2012 | Marta Coscia; Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Marta Robino; Marina Ruggeri; Daniela Drandi; Paola Omedè; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia | |
| IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells | 2011 | Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M. | |
| Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross Talk between V{gamma}9V{delta}2 T Cells, {alpha}{beta} CD8+ T Cells, Regulatory T Cells, and Dendritic Cells | 2011 | Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M | |
| Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: Diagnostic challenges and therapeutic options: Two case reports | 2020 | Elba S.; Castellino A.; Soriasio R.; Castellino C.; Bonferroni M.; Mattei D.; Strola G.; Drandi D.; Mordini N.; Foglietta M.; Rapezzi D.; Celeghini I.; Grasso M.; Giordano F.; Fraternali Orcioni G.; Massaia M. | |
| Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients. | 2000 | BESOSTRI B ;BEGGIATO E ;BIANCHI A ;MARIANI S ;COSCIA M ;PEOLA S ;FOGLIETTA M ;BOCCADORO M ;PILERI A ;MORETTA L ;MASSAIA M | |
| Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy | 2004 | COSCIA M; MARIANI S; BATTAGLIO S; DI BELLO C; FIORE F; FOGLIETTA M; PILERI A; BOCCADORO M; MASSAIA M | |
| Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. | 2014 | P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia. |